Trevena, Inc. (TRVN)
OTCMKTS
· Delayed Price · Currency is USD
1.250
+0.050 (4.17%)
Mar 28, 2025, 4:00 PM EST
Trevena Employees
Trevena had 23 employees as of December 31, 2023. The number of employees decreased by 12 or -34.29% compared to the previous year.
Employees
23
Change (1Y)
-12
Growth (1Y)
-34.29%
Revenue / Employee
$23,739
Profits / Employee
-$1,479,826
Market Cap
1.08M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Trevena News
- 5 months ago - Trevena Reports Third Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Trevena receives Nasdaq delisting notification - Seeking Alpha
- 6 months ago - Trevena Announces Receipt of Nasdaq Delisting Notification - GlobeNewsWire
- 9 months ago - Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing - GlobeNewsWire
- 10 months ago - What's Going On With Neurological Disease Focused Trevena On Thursday? - Benzinga
- 10 months ago - Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models - GlobeNewsWire
- 11 months ago - Trevena Reports First Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 1 year ago - Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update - GlobeNewsWire